Centene Corporation (0HVB.L)
USD 59.65
(2.35%)
USD 59.65
(2.35%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 17.69 Billion USD | -17.03% |
| 2022 | 21.33 Billion USD | -5.86% |
| 2021 | 22.66 Billion USD | 23.72% |
| 2020 | 18.31 Billion USD | 26.25% |
| 2019 | 14.5 Billion USD | 117.01% |
| 2018 | 6.68 Billion USD | 42.29% |
| 2017 | 4.69 Billion USD | 0.95% |
| 2016 | 4.65 Billion USD | 281.24% |
| 2015 | 1.22 Billion USD | 39.7% |
| 2014 | 874 Million USD | 31.23% |
| 2013 | 666 Million USD | 0.0% |
| 2012 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 17.51 Billion USD | -2.7% |
| 2024 Q1 | 18 Billion USD | -4.65% |
| 2024 Q3 | 17.6 Billion USD | 0.52% |
| 2023 Q3 | 19.1 Billion USD | -10.52% |
| 2023 Q2 | 21.35 Billion USD | -1.33% |
| 2023 Q1 | 21.64 Billion USD | 1.44% |
| 2023 FY | 18.87 Billion USD | -11.51% |
| 2023 Q4 | 18.87 Billion USD | -1.2% |
| 2022 Q3 | 21.56 Billion USD | -2.99% |
| 2022 Q2 | 22.22 Billion USD | -1.95% |
| 2022 Q1 | 22.66 Billion USD | 0.04% |
| 2022 FY | 21.33 Billion USD | -5.86% |
| 2022 Q4 | 21.33 Billion USD | -1.07% |
| 2021 Q1 | 18.32 Billion USD | 10.88% |
| 2021 Q2 | 18.31 Billion USD | -0.08% |
| 2021 FY | 22.66 Billion USD | 23.72% |
| 2021 Q3 | 22.69 Billion USD | 23.95% |
| 2021 Q4 | 22.66 Billion USD | -0.17% |
| 2020 Q1 | 17.03 Billion USD | 25.9% |
| 2020 FY | 18.31 Billion USD | 26.25% |
| 2020 Q3 | 16.6 Billion USD | 0.19% |
| 2020 Q2 | 16.56 Billion USD | -2.71% |
| 2020 Q4 | 16.52 Billion USD | -0.43% |
| 2019 Q2 | 6.93 Billion USD | 2.11% |
| 2019 Q1 | 6.78 Billion USD | 1.36% |
| 2019 FY | 14.5 Billion USD | 117.01% |
| 2019 Q4 | 13.52 Billion USD | 96.78% |
| 2019 Q3 | 6.87 Billion USD | -0.81% |
| 2018 Q1 | 5.29 Billion USD | 11.43% |
| 2018 FY | 6.68 Billion USD | 42.29% |
| 2018 Q3 | 6.52 Billion USD | 1.79% |
| 2018 Q4 | 6.69 Billion USD | 2.6% |
| 2018 Q2 | 6.41 Billion USD | 21.15% |
| 2017 Q3 | 4.77 Billion USD | 0.02% |
| 2017 Q4 | 4.74 Billion USD | -0.44% |
| 2017 Q1 | 4.71 Billion USD | 0.04% |
| 2017 Q2 | 4.76 Billion USD | 1.15% |
| 2017 FY | 4.69 Billion USD | 0.95% |
| 2016 Q1 | 4.28 Billion USD | 251.89% |
| 2016 FY | 4.65 Billion USD | 281.24% |
| 2016 Q4 | 4.71 Billion USD | 25.88% |
| 2016 Q3 | 3.74 Billion USD | 2.6% |
| 2016 Q2 | 3.64 Billion USD | -14.86% |
| 2015 Q3 | 1.27 Billion USD | 11.54% |
| 2015 Q2 | 1.14 Billion USD | 1.69% |
| 2015 Q1 | 1.12 Billion USD | 28.72% |
| 2015 FY | 1.22 Billion USD | 39.7% |
| 2015 Q4 | 1.21 Billion USD | -4.55% |
| 2014 Q3 | 950.97 Million USD | 7.47% |
| 2014 Q2 | 884.89 Million USD | 9.12% |
| 2014 Q1 | 810.97 Million USD | 21.77% |
| 2014 FY | 874 Million USD | 31.23% |
| 2014 Q4 | 874 Million USD | -8.09% |
| 2013 Q4 | 666 Million USD | 28.59% |
| 2013 Q2 | 548.47 Million USD | 2.95% |
| 2013 Q3 | 517.93 Million USD | -5.57% |
| 2013 Q1 | 532.73 Million USD | 0.0% |
| 2013 FY | 666 Million USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -147600.91% |
| Accuray Incorporated | 172.15 Million USD | -10180.792% |
| Align Technology, Inc. | 96.96 Million USD | -18152.413% |
| Elevance Health Inc. | 25.12 Billion USD | 29.542% |
| AxoGen, Inc. | 69.29 Million USD | -25442.631% |
| Boston Scientific Corporation | 9.09 Billion USD | -94.559% |
| CVS Health Corporation | 79.38 Billion USD | 77.705% |
| Cardinal Health, Inc. | 5.6 Billion USD | -215.546% |
| DaVita Inc. | 11.11 Billion USD | -59.215% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 57.718% |
| Hologic, Inc. | 2.53 Billion USD | -598.296% |
| Humana Inc. | 10.21 Billion USD | -73.299% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | -1767.219% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | -197.252% |
| Masimo Corporation | 970 Million USD | -1724.639% |
| McKesson Corporation | 5.47 Billion USD | -223.447% |
| Patterson Companies, Inc. | 762.94 Million USD | -2219.842% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | -229.652% |
| ResMed Inc. | 873.93 Million USD | -1925.208% |
| Henry Schein, Inc. | 2.74 Billion USD | -545.713% |
| Teladoc Health, Inc. | 1.59 Billion USD | -1011.553% |
| Universal Health Services, Inc. | 5.36 Billion USD | -229.797% |
| Veeva Systems Inc. | 55.77 Million USD | -31632.855% |
| Baxter International Inc. | 14.36 Billion USD | -23.218% |
| Becton, Dickinson and Company | 15.87 Billion USD | -11.462% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -19609.354% |
| Danaher Corporation | 19.35 Billion USD | 8.561% |
| Stryker Corporation | 12.99 Billion USD | -36.199% |
| Medtronic plc | 24.96 Billion USD | 29.099% |